WikiFX

Rispondi

Based on my close review of C&S, I must be transparent: I cannot provide a reliable breakdown of the total trading costs for indices like the US100 through this broker. My primary reason is that C&S does not offer index trading at all, according to their latest available information. The only supported instruments are commodities, which immediately rules out indices such as the US100 from their product list. For me, this is a significant drawback, as index CFDs are an essential part of my trading strategy and cost calculations are fundamental to risk management. Additionally, even if index trading were available, I would be hesitant to proceed due to the lack of regulatory oversight, absent demo accounts, and minimal transparency around account conditions and costs. When evaluating a broker, especially for asset classes involving fast-moving indices, I require explicit and published details on spreads, commissions, overnight fees, and margin requirements. With C&S, this level of disclosure is simply not present. In my experience, trading without regulation and clear cost structures introduces unjustifiable risk—particularly with YMYL considerations in mind—so I strongly advise seeking regulated brokers who publish full information before even thinking about any serious capital allocation. For now, C&S is not a broker I can responsibly consider for index trading or calculate related costs with confidence.